お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:医薬品における再生医療:テーマ別調査
市場調査レポート
商品コード
974407

医薬品における再生医療:テーマ別調査

Regenerative Medicine in Pharma - Thematic Research

出版日: | 発行: GlobalData | ページ情報: 英文 156 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.20円
医薬品における再生医療:テーマ別調査
出版日: 2020年11月30日
発行: GlobalData
ページ情報: 英文 156 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

遺伝子治療は最も有益な再生医療分野であると広く期待されていますが、この市場はまた、治療のコストが高く、アクセスが制限される可能性があるため、減速すると予想されます。

既存のプログラムは再生医療の承認と開発を促進しますが、特に治療処置のための償還システムが保証されています。

当レポートでは、医薬品における再生医療について調査し、主な動向、革新的な製品と技術、市場セグメント、および将来の世界の再生医療市場に影響を与える可能性のある企業などについて分析しています。

目次

  • エグゼクティブサマリー
  • 再生医療の概要
  • 動向
  • バリューチェーン
  • 市販製品
  • パイプライン製品
  • 市場分析と取引
  • 企業
  • 規制および市場アクセス
  • 市場機会、課題、およびアンメットニーズ

付録

  • お問い合わせ
目次
Product Code: GDHCHT211

Regenerative medicine is a multidisciplinary field that seeks to develop the science and tools that can help repair, augment, replace, or regenerate damaged or diseased human cells, tissues, genes, organs, or metabolic processes, to restore normal function. It may involve the transplantation of stem cells, progenitor cells, or tissue, stimulation of the body's own repair mechanisms, or the use of cells as delivery vehicles for therapeutic agents such as genes and cytokines.

It is widely anticipated that Gene therapy is the most valuable regenerative medicine sector however, this market is also expected to be slowed down by high cost of therapies, which may limit its accessibility.

Existing programs will facilitate the approval and development of regenerative medicines, however, a reimbursement system especially for curative therapies is warranted.

GlobalData's Regenerative Medicine in Pharma report combines primary research from a cross-specialty panel of experts with in-house analyst expertise to provide an assessment of the development landscape.

This report assesses -

  • Physician perceptions on Regenerative Medicine usage in clinical practice in the US, 5EU (France, Germany, Italy, Spain, and the UK), Japan and South Korea.
  • Regenerative Medicine Marketed and Pipeline products.
  • Opportunities and Challenges
  • Market analysis and Forecast
  • Unmet Needs
  • Regulation and Market Access
  • The report combines information obtained from secondary sources and primary research with specialists and physicians from different therapy areas (oncology, cardiology, and ophthalmology).

Scope

  • Components of the slide deck include primary and secondary research:
  • Quotes from key opinion leaders and payers
  • Summary of Regenerative Medicine product definitions and classifications
  • Overview of key Regenerative Medicine marketed products and key pipeline Regenerative Medicine products
  • Trends in Regenerative Medicine market
  • Call-outs of key information and details
  • Insight from GlobalData's specialist healthcare analysts

Reasons to Buy

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global Regenerative Medicine market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Regenerative Medicine market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Table of Contents

  • Executive Summary
  • Regenerative Medicine Overview
  • Trends
  • Value Chain
  • Marketed Products
  • Pipeline Products
  • Market Analysis and Deals
  • Companies
  • Regulatory and Market Access
  • Opportunities, Challenges, and Unmet Needs

Appendix

  • Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.